- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Chimeric antigen receptor T‑cell therapy—a hematological success story ; volume:11 ; number:2 ; day:6 ; month:6 ; year:2018 ; pages:116-121 ; date:6.2018
Magazine of European Medical Oncology ; 11, Heft 2 (6.6.2018), 116-121, 6.2018
- Creator
-
Wohlfarth, Philipp
- Contributor
-
Worel, Nina
Hopfinger, Georg
SpringerLink (Online service)
- DOI
-
10.1007/s12254-018-0409-x
- URN
-
urn:nbn:de:101:1-2018082823473270980603
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wohlfarth, Philipp
- Worel, Nina
- Hopfinger, Georg
- SpringerLink (Online service)
Other Objects (12)
Chimeric Antigen Receptor T-Cell Therapy
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
Chimeric Antigen Receptor T-Cell Therapy
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
Chimeric Antigen Receptor T-Cell Therapy
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies